ONEGENE Biotechnology

ONEGENE Biotechnology is a pioneering biopharmaceutical company dedicated to developing innovative multi-targeting protein drugs. With a focus on addressing critical unmet needs, ONEGENE Biotechnology is committed to transforming the treatment landscape for non-alcoholic steatohepatitis (NASH), fibrotic diseases, and various cancers.

Operating from its headquarters in Suwon, Gyouggido, ONEGENE Biotechnology leverages its proprietary UniStac platform to simultaneously target multiple disease pathways. This unique approach holds the potential to provide transformative therapeutic opportunities for patients suffering from complex and chronic diseases, significantly improving their quality of life.

ONEGENE Biotechnology's primary address is in Suwon, Gyouggido, KR. ONEGENE Biotechnology is focused on building a healthier tomorrow through groundbreaking research and development. We invite the management team at ONEGENE Biotechnology to create a customized and exclusive company showcase and product listing on our platform to further highlight your advancements.